C

CARsgen Therapeutics Holdings
2171

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$12.82B
EV
HK$11.43B
Shares Outstanding
563.62M
Beta
0.48

Wall Street View

Analyst Rating
UNDERPERFORM
Analyst Target Price
HK$9.31
P/E 2025E
-
P/Revenue 2025E
134.53x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CARsgen Therapeutics Holdings Limited

gainify

C

CARsgen Therapeutics Holdings Limited

2171

CARsgen Therapeutics Holdings Limited, an investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United St...

Sector

Healthcare

Industry

Biotechnology

CEO

Li, Zonghai

Employees

465

IPO Date

2021-06-18

Headquarters

No. 466 Yindu Road, 1st Floor, Building 2, Xuhui District, Shanghai China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.